NeoGenomics Acquires Pathline
April 7, 2025
NeoGenomics, Inc. (NASDAQ: NEO) has completed its acquisition of Pathline, LLC, a CLIA/CAP/NYS-certified pathology laboratory headquartered in Ramsey, New Jersey. The deal strengthens NeoGenomics' commercial presence in the Northeast United States and expands its molecular and hematology-oncology testing capabilities and access to its oncology test menu.
- Buyers
- NeoGenomics, Inc.
- Targets
- Pathline, LLC
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
LabGenomics USA LLC Acquires QDx Pathology
September 5, 2023
Healthcare Services
LabGenomics USA LLC, a subsidiary of South Korea–based LabGenomics Co., Ltd., has acquired QDx Pathology, a U.S. clinical and molecular pathology laboratory. The deal, signed in August 2023, is intended to accelerate LabGenomics' entry and expansion into the North American diagnostics market by combining QDx's lab services with LabGenomics' NGS-based molecular diagnostics capabilities.
-
SourceBio International plc Acquires LDPath Limited
March 29, 2022
Healthcare Services
SourceBio International plc has completed a strategic acquisition of LDPath Limited, a London-based digital pathology testing provider. The deal expands SourceBio's digital and AI-enabled pathology capabilities and creates a larger private provider of cellular and digital pathology services for the U.K. healthcare market.
-
StageBio Acquires TPL Path Labs
October 21, 2020
Healthcare Services
StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.
-
StatLab Medical Products Acquires CellPath Ltd.
June 8, 2022
Medical Devices
StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, acquired UK-based CellPath Ltd., a manufacturer and supplier focused on the histology and cytology markets. The deal adds injection-molding manufacturing capabilities, proprietary products (including the CellNass archiving service), and an established European customer base to support StatLab's international growth.
-
Lighthouse Lab Services Acquires Pathology Lab Solutions
May 18, 2023
Healthcare Services
Lighthouse Lab Services (LLS) has acquired Pathology Lab Solutions (PLS), a pathology-focused consulting and equipment company that helps physician practices establish in‑office pathology labs. The acquisition expands Lighthouse’s service offering to include pathology-specific lab build, compliance, LIS, and revenue cycle management support for GI and other physician practices.
-
PathGroup Acquires DermLab
August 30, 2021
Healthcare Services
PathGroup, a leading provider of anatomic, clinical, molecular and digital pathology services, has acquired DermLab, an independent dermatopathology laboratory based in Birmingham, Alabama. The acquisition expands PathGroup's dermatopathology capabilities and strengthens its presence in the Southeastern United States as an add-on to its existing portfolio.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.